Qualitative or quantitative protein defects in neuromuscular diseases
MONDO:001613930 clinical trials for this condition and its sub-types, 0 tagged with Qualitative or quantitative protein defects in neuromuscular diseases itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Qualitative or quantitative protein defects in neuromuscular diseases
-
Sarcoglycanopathy 3 trials · 10 incl. sub-types
4 sub-types
- Qualitative or quantitative defects of beta-sarcoglycan 0 trials · 5 incl. sub-types Sub-types →
- Qualitative or quantitative defects of gamma-sarcoglycan 1 trial · 4 incl. sub-types Sub-types →
- Qualitative or quantitative defects of alpha-sarcoglycan 0 trials · 3 incl. sub-types Sub-types →
- Qualitative or quantitative defects of delta-sarcoglycan 0 trials · 2 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan 0 trials · 8 incl. sub-types
1 sub-type
- Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin 4 trials · 5 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of titin 0 trials · 4 incl. sub-types
1 sub-type
- TTN-related myopathy 2 trials · 4 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of tropomyosin 0 trials · 4 incl. sub-types
5 sub-types
- TPM2-related myopathy 1 trial · 3 incl. sub-types Sub-types →
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- TPM3-related myopathy 1 trial Sub-types →
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types
4 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-actin 0 trials · 2 incl. sub-types
5 sub-types
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- Adult-onset nemaline myopathy 0 trials
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of nebulin 0 trials · 2 incl. sub-types
5 sub-types
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- Adult-onset nemaline myopathy 0 trials
- Intermediate nemaline myopathy 0 trials Sub-types →
- Typical nemaline myopathy 0 trials Sub-types →
-
Collagen 6-related myopathy 1 trial
3 sub-types
- Bethlem myopathy 1A 0 trials
- Ullrich congenital muscular dystrophy 1A 0 trials
- Myosclerosis 0 trials
-
Neuromuscular disease caused by qualitative or quantitative defects of myofibrillar proteins 0 trials · 1 incl. sub-types
4 sub-types
- Qualitative or quantitative defects of desmin 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of alphaB-cristallin 0 trials
- Qualitative or quantitative defects of filamin C 0 trials Sub-types →
- Qualitative or quantitative defects of protein ZASP 0 trials Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of selenoprotein N1 0 trials · 1 incl. sub-types
2 sub-types
- Multiminicore myopathy 1 trial Sub-types →
- Rigid spine syndrome 0 trials · 1 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types
2 sub-types
-
Alpha-actinopathy 0 trials
4 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Progressive scapulohumeroperoneal distal myopathy 0 trials
- Zebra body myopathy 0 trials
-
Caveolinopathy 0 trials
1 sub-type
-
2 sub-types
-
3 sub-types
- MYH7-related skeletal myopathy 0 trials
- Congenital myopathy 7A, myosin storage, autosomal dominant 0 trials
- Hyaline body myopathy 0 trials
-
2 sub-types
-
2 sub-types
- Brody myopathy 0 trials
- Myopathy due to calsequestrin and SERCA1 protein overload 0 trials
Most studied deeper sub-types
-
Experimental gene therapy for rare muscle disease shows early promise but study halted
Disease control Stopped earlyThis study tested a gene therapy called SRP-9003 for people with limb-girdle muscular dystrophy type 2E (LGMD2E), a rare genetic disease that causes muscle weakness. The treatment aimed to deliver a working gene to muscle cells to help them produce a missing protein. Only 6 peopl…
Phase 1/2 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental gene therapy for rare muscle disease tested in just 2 people
Disease control Stopped earlyThis was a very early (Phase 1) study testing a gene therapy called SRP-6004 for people with limb girdle muscular dystrophy type 2B/R2, a rare muscle-weakening disease. The goal was to see if a single IV infusion of the therapy is safe and can help the body produce a missing prot…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
Experimental gene therapy tested for rare muscular dystrophy
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SRP-9004 in just 4 people with limb girdle muscular dystrophy type 2D/R3, a rare muscle-weakening disease. The main goal was to check safety, not effectiveness. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:47 UTC